Related Experiment Videos
Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity
Journal of the National Cancer Institute
|July 1, 1975
Abstract:
After one dose of adriamycin, a subacute cardiomyopathy was observed in the mouse by both light and electron microscopy. The microscopic alterations were characterized by single-cell necrosis and mitochondrial degeneration. These lesions were similar to those seen in man and shortly preceded fatal toxicity.
Insights
Adriamycin causes subacute cardiomyopathy in mice, characterized by cell death and mitochondrial damage. These findings mirror human responses and precede lethal toxicity.
Area of Science:
- Cardiology
- Toxicology
- Cell Biology
Background:
- Adriamycin is a widely used chemotherapy agent.
- Cardiotoxicity is a known side effect of adriamycin treatment.
- Understanding the early cellular mechanisms of adriamycin-induced cardiotoxicity is crucial for patient management.
Purpose of the Study:
- To investigate the subacute cardiac effects of a single adriamycin dose in a mouse model.
- To characterize the light and electron microscopic alterations in cardiac tissue following adriamycin exposure.
- To compare the observed mouse cardiac lesions with those reported in human adriamycin cardiotoxicity.
Main Methods:
- Administration of a single dose of adriamycin to mice.
- Evaluation of cardiac tissue using light microscopy.
- Evaluation of cardiac tissue using electron microscopy.
Main Results:
- Subacute cardiomyopathy was observed after a single adriamycin dose.
- Microscopic analysis revealed single-cell necrosis and mitochondrial degeneration.
- The observed cardiac lesions in mice were similar to those documented in human adriamycin cardiotoxicity.
Conclusions:
- A single dose of adriamycin can induce subacute cardiomyopathy in mice.
- Mitochondrial degeneration and single-cell necrosis are key early pathological features.
- The mouse model effectively recapitulates human adriamycin cardiotoxicity, preceding fatal outcomes.